mFOLFIRINOX trials for Colorectal cancer

All mFOLFIRINOX trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying mFOLFIRINOX for Colorectal cancer

• A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
  NCT06179160 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 34 locations
• Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
  NCT05179889 · Phase: Phase 2, Phase 3 · Ages: 20 Years to 75 Years · Sex: All (male and female) · 1 location
• BBO-11818 in Adult Subjects With KRAS Mutant Cancer
  NCT06917079 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
• Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
  NCT05174169 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1066 locations

Common questions

How many trials study mFOLFIRINOX for Colorectal cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.